Intellectual property

Protected innovation built for a new category of care.

ISO Metrik’s patent portfolio protects core elements of the platform’s device design, modular resistance architecture, and provider-directed treatment methodology.

Patent status, claim scope, ownership, and national-phase records can change. Confirm current legal status before relying on any listing.

Clinical research laboratory with facial anatomy models and analysis displays
22Patents protecting the platform
2019PCT family filing year
8Listed national or regional records
GlobalMulti-jurisdiction portfolio

Comprehensive protection

From device architecture to clinical application.

The portfolio is designed to protect how the platform fits, applies resistance, targets facial and oral-motor musculature, and supports progressive rehabilitation. Patent status, scope, and jurisdiction vary by filing.

Protected areas

The portfolio spans structure, resistance, methodology, and progression.

01

Device design

Structural elements supporting intraoral anchoring, perioral engagement, and clinical fitting.

02

Resistance architecture

Modular components that enable selectable and progressive loading parameters.

03

Treatment methodology

Provider-directed applications of Isometric Therapy, Isotonic Therapy, and Isokinetic-Style Cadence Training principles.

04

Clinical progression

Structured approaches to assessment, monitoring, and advancement across the patient journey.

Published patent family

Facial Resistance Training Device and Method.

The published patent family derives from the 2019 Patent Cooperation Treaty filing identified by ISO Metrik.

  • International application: PCT/US2019/036373
  • Primary PCT publication: WO 2019/237116 A1
  • National and regional status varies by jurisdiction
  • Legal-status confirmation should come from the applicable patent office or qualified counsel
ISO Metrik device architecture protected by the patent portfolio

Patent numbers

Published national and regional records.

The identifiers below reflect the portfolio information supplied by ISO Metrik; current status should be independently confirmed.

  1. 1

    United States — US 10,549,151 B2

    Granted in 2020.

  2. 2

    United States — US 11,278,762 B2

    Granted in 2022.

  3. 3

    European Patent — EP 3,801,786 B1

    Granted in 2023.

  4. 4

    Japan — JP 7,346,560 B2

    Granted in 2023.

  5. 5

    China — CN 112770818 B

    Granted in 2022.

  6. 6

    South Korea — KR 20210028183 A

    National record published in 2021.

  7. 7

    Canada — CA 3,120,074 A1

    Pending in the supplied portfolio record.

  8. 8

    Thailand — national-phase filing

    Pending; no publication number was listed in the supplied portfolio record.

Portfolio inquiries

Confirm the information needed for your purpose.

Different inquiries require different levels of legal-status and ownership verification.

01

Licensing

Contact ISO Metrik for authorized discussions about portfolio rights, technology access, and permitted uses.

02

Legal status

Verify current grant, pending, maintenance, ownership, and jurisdictional information through official records and qualified counsel.

03

Technical diligence

Review the applicable publication, claims, family relationships, and prosecution history rather than relying on a marketing summary.

Next step

Request patent information from ISO Metrik.

Contact the team for licensing inquiries, supplied portfolio materials, or coordination of a formal legal-status review.